Articles

"Disease-modification" trials in Parkinson disease: target populations, endpoints and study design

However, presently, no fully satisfying efficacy "disease-modification" study design exists, and no drug has yet been approved for that indication....

A Year in Neurology

Multiple Sclerosis In multiple sclerosis (MS), 2008 has been a big year in terms of diseasemodifying therapies. Results from key clinical trials...

Advances in the Role of Neuroimaging to Monitor Disease Progression in Parkinson’s Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder and affects more than one in 100 people over the age of 65.1 The...

Apomorphine in the Treatment of Parkinson’s Disease

The initiation of antiparkinsonian treatment in early Parkinson’s disease (PD) is followed by a phase of good to excellent symptomatic response in...

Applicability and Benefit of Enteral Levodopa/Carbidopa Infusion in Advanced Parkinson’s Disease

In recent years, a novel gel form of levodopa/carbidopa (Duodopa®) has enabled infusion through percutaneous endoscopic gastrostomy (PEG) directly...

Approaches to the Diagnosis of Parkinson’s Disease during the Pre-motor Phase

The prevalence of Parkinson’s disease (PD) is now estimated to be approximately 1 % in individuals over 60 years of age, with 4.1–4.6 million...

As Use of Herbal Remedies Soars, Patients Taking These and Cardiovascular Medications May be at Heightened Risk of Dangerous, Potentially Life-Threatening Interactions

"Many people have a false sense of security about these herbal products because they are seen as 'natural,'" said Arshad Jahangir, M.D.,...

Behavioral and Neurophysiological Characteristics of Lewy Body Dementia Implications for Intervention

Another common form of dementia is Lewy body dementia (LBD). As its name suggests, LBD is characterized by the presence of Lewy bodies—...

Challenges for Epidemiological Research of Pesticide Exposure and Parkinson’s Disease

A slow progressive loss of dopaminergic neurons accompanies normal aging, and exposure to harmful environmental factors may cause PD by accelerating...

Challenges in the Long-term Evolution of Parkinson’s Disease

There is a change in the clinical manifestation of Parkinson’s disease (PD) over time. Figure 1 provides a schematic overview of this process,...

Continuous Duodenal Levodopa Infusion – The Barcelona Experience

Our as-yet quite short experience with continuous levodopa infusion (Duodopa) therapy at the University of Barcelona began 18 months ago. We decided...

Continuous Intra-intestinal Infusion of Levodopa/Carbidopa in Advanced Parkinson s Disease

The Drug Delivery System The first studies of intravenous and intraduodenal infusions of levodopa utilized water solutions of levodopa. The...

Deep Brain Stimulation

However, at this time, many questions are still unanswered and many options are still debated. What is the appropriate structure to stimulate or to...

Deep Brain Stimulation - What Has Been Learned and Where it is Going

Advantages and Disadvantages of DBS DBS has many advantages over other surgical approaches to PD. It is a reversible procedure that allows the option...

Deep Brain Stimulation for Parkinson's Disease

However, as the disease progresses, disabling medication-related side effects, particularly motor fluctuations and dyskinesia, often occur and can...

Dementia Associated with Parkinsons Disease

This article provides an update on the epidemiological, clinical and pathological features of PD-D and recent treatment efforts Epidemiology...

Depression and Parkinson’s Disease

The estimated prevalence of depression in PD varies according to the type of mood assessment applied (interview versus self-report questionnaire),...

Development of Parkinsonism following exposure to aripiprazole: two case reports

Introduction Aripiprazole is one of the recently introduced atypical antipsychotics (AAs) used in the treatment of psychosis related to schizophrenia...

Dopamine Systems in Parkinson's Disease and L-DOPA-induced Dyskinesia What Goes Wrong?

Since the primary pathological consequences of PD are due to the degeneration of a specific set of neurons that specifically release the...

Dual Task Interference in Parkinson’s Disease

Performing two tasks simultaneously (dual task performance) is a frequent activity in human life. However, performing dual tasks can be difficult....

Copyright® 2012 Touch Group PLC. All rights reserved.
Touch Neurology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.